Use of fulvestrant in the treatment of resistant breast cancer

Details for Australian Patent Application No. 2001244372 (hide)

Owner AstraZeneca AB

Inventors Thurlimann, Beat

Agent Davies Collison Cave

Pub. Number AU-B-2001244372

PCT Pub. Number WO01/74366

Priority 0008172 05.04.00 GB

Filing date 2 April 2001

Wipo publication date 15 October 2001

Acceptance publication date 16 February 2006

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 February 2006 Application Accepted

  Published as AU-B-2001244372

22 June 2006 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001244376

2001244362